Literature DB >> 9203972

Two distinct pathways of human macrophage differentiation are mediated by interferon-gamma and interleukin-10.

T Orlikowsky1, T Olikowsky, Z Q Wang, A Dudhane, H Horowitz, B Conti, M K Hoffmann.   

Abstract

Forming cellular conjugates with T cells, macrophages can help their targets to mount an immune response or they can destroy the targeted T cell. The two functions are performed by two distinct macrophage subsets that can be distinguished by cell surface marker phenotypes, B7+ CD16- and B7- CD16+. Interferon-gamma (IFN-gamma) induces the former, interleukin-10 (IL-10) induces the latter phenotype. The two macrophage differentiation pathways are mutually exclusive; each cytokine inhibits the effect of the other cytokine. The second messenger cAMP enhances the macrophage B7 expression and suppresses the macrophage CD16 expression. However, together with IL-10, cAMP blocks the generation of both macrophage phenotypes. In the chimpanzee we noted deviations from this differentiation pattern that are suggestive of an enhanced IL-10 presence in the primate environment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203972      PMCID: PMC1364041          DOI: 10.1046/j.1365-2567.1997.00204.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

Authors:  L Ding; P S Linsley; L Y Huang; R N Germain; E M Shevach
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

Review 2.  The cell biology of macrophage activation.

Authors:  D O Adams; T A Hamilton
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 3.  The role of the CD28 receptor during T cell responses to antigen.

Authors:  P S Linsley; J A Ledbetter
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

4.  Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes.

Authors:  J C Cambier; M K Newell; L B Justement; J C McGuire; K L Leach; Z Z Chen
Journal:  Nature       Date:  1987 Jun 18-24       Impact factor: 49.962

5.  Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants.

Authors:  H Schuitemaker; L Meyaard; N A Kootstra; R Dubbes; S A Otto; M Tersmette; J L Heeney; F Miedema
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

6.  Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.

Authors:  N Nabavi; G J Freeman; A Gault; D Godfrey; L M Nadler; L H Glimcher
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

Review 7.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  Transmembrane signaling through B cell MHC class II molecules: anti-Ia antibodies induce protein kinase C translocation to the nuclear fraction.

Authors:  Z Z Chen; J C McGuire; K L Leach; J C Cambier
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

9.  Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals.

Authors:  N Oyaizu; T W McCloskey; M Coronesi; N Chirmule; V S Kalyanaraman; S Pahwa
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  9 in total

1.  CD14+CD16+ monocyte subpopulation in Kawasaki disease.

Authors:  K Katayama; T Matsubara; M Fujiwara; M Koga; S Furukawa
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo.

Authors:  Y Furukawa; G Becker; J L Stinn; K Shimizu; P Libby; R N Mitchell
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.

Authors:  I Desombere; T Cao; Y Gijbels; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

4.  Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion.

Authors:  T Orlikowsky; Z Wang; A Dudhane; R Mittler; V Trejo; G E Dannecker; D Niethammer; M K Hoffmann
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

5.  Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines.

Authors:  L P Erwig; K Stewart; A J Rees
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

6.  Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcgammaRIII) whose engagement blocks the cell death programme and facilitates differentiation.

Authors:  Z Q Wang; A S Bapat; R J Rayanade; A S Dagtas; M K Hoffmann
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

7.  Cytokine production is altered in monocytes from children with hemolytic uremic syndrome.

Authors:  Gabriela C Fernández; María V Ramos; Veronica I Landoni; Leticia V Bentancor; Romina J Fernández-Brando; Ramón Exeni; María Del Carmen Laso; Andrea Exeni; Irene Grimoldi; Martín A Isturiz; Marina S Palermo
Journal:  J Clin Immunol       Date:  2012-01-08       Impact factor: 8.317

8.  Xuebijing injection improves the respiratory function in rabbits with oleic acid-induced acute lung injury by inhibiting IL-6 expression and promoting IL-10 expression at the protein and mRNA levels.

Authors:  Yuxia Wang; Mingli Ji; Lei Wang; Liping Chen; Jing Li
Journal:  Exp Ther Med       Date:  2014-09-05       Impact factor: 2.447

9.  CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes.

Authors:  Wei Hseun Yeap; Kok Loon Wong; Noriko Shimasaki; Esmeralda Chi Yuan Teo; Jeffrey Kim Siang Quek; Hao Xiang Yong; Colin Phipps Diong; Antonio Bertoletti; Yeh Ching Linn; Siew Cheng Wong
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.